EUVIMEDEUVIMED entdecken
Crossref

Phosphorus Dendrimers Functionalized with Anti-Tuberculosis Drugs: Synthesis and Biological Evaluation

Charlotte Aparici, Pradip Malik, Atri Mukhopadhyay, Kevin Antraygues, Arunava Dasgupta, Carine Duhayon, Anne-Marie Caminade, Vania Bernardes-Génisson, Valérie Maraval

Biomacromolecules · 29.10.2026

DOI: 10.1021/acs.biomac.6c01574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 29.10.2026. Verfasst von Charlotte Aparici und 8 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation, Council of Scientific and Industrial Research, India, University Grants Commission.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis remains a major global health challenge, motivating the development of innovative drug delivery strategies. Herein, polyphosphorhydrazone dendrimers were investigated as covalent nanocarriers for anti-tuberculosis drugs. Three dendrimer families, including two novel glycoluril-based architectures, were synthesized and functionalized with several anti-tuberculosis drugs or fragments thereof (isoniazid, pyrazinamide, and thioacetazone), via cleavable acylhydrazone or ester linkages. Isoniazid-functionalized dendrimers bearing acylhydrazone linkages displayed the highest activity against Mycobacterium tuberculosis, with a minimum inhibitory concentration as low as 0.097 μM per dendrimer for the glycoluril-cored generation-zero dendrimer, corresponding to 0.39 μM per isoniazid fragment, an approximately two-fold improvement over free isoniazid. In contrast, ester-functionalized dendrimers were inactive. The most potent dendrimers retained activity against rifampicin-, ethambutol-, and streptomycin-resistant strains, but were inactive against isoniazid-resistant strains and non-tuberculous mycobacteria. Cytotoxicity studies revealed a favorable selectivity index exceeding 100. These results identify low-generation glycoluril-cored polyphosphorhydrazone dendrimers as promising platforms for anti-tuberculosis drug delivery.

Förderung

  • Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation
  • Council of Scientific and Industrial Research, India
  • University Grants Commission
  • Université de Toulouse
  • Centre National de la Recherche Scientifique

Zitieren

APA

Aparici, C., Malik, P., Mukhopadhyay, A., Antraygues, K., Dasgupta, A., Duhayon, C., Caminade, A., Bernardes-Génisson, V., & Maraval, V. (2026). Phosphorus Dendrimers Functionalized with Anti-Tuberculosis Drugs: Synthesis and Biological Evaluation. Biomacromolecules. https://doi.org/10.1021/acs.biomac.6c01574

Vancouver

Aparici C, Malik P, Mukhopadhyay A, Antraygues K, Dasgupta A, Duhayon C, et al. Phosphorus Dendrimers Functionalized with Anti-Tuberculosis Drugs: Synthesis and Biological Evaluation. Biomacromolecules. 2026. doi:10.1021/acs.biomac.6c01574

BibTeX
@article{Aparici2026,
  author = {Aparici, Charlotte and Malik, Pradip and Mukhopadhyay, Atri and Antraygues, Kevin and Dasgupta, Arunava and Duhayon, Carine and Caminade, Anne-Marie and Bernardes-Génisson, Vania and Maraval, Valérie},
  title = {Phosphorus Dendrimers Functionalized with Anti-Tuberculosis Drugs: Synthesis and Biological Evaluation},
  journal = {Biomacromolecules},
  year = {2026},
  doi = {10.1021/acs.biomac.6c01574}
}
Kostenlos starten →